Ignite Creation Date:
2025-12-25 @ 4:59 AM
Ignite Modification Date:
2026-03-09 @ 3:54 AM
Study NCT ID:
NCT03906318
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2022-09-30
First Post:
2019-04-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Expanded Access Use of Itacitinib to Treat a Single Patient With Aplastic Anemia
Sponsor:
Incyte Corporation
Organization:
Study Overview
Official Title:
Expanded Access Use of Itacitinib to Treat a Single Patient With Aplastic Anemia
Status:
NO_LONGER_AVAILABLE
Status Verified Date:
2022-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Expanded Access Use of Itacitinib to Treat a Single Patient With Aplastic Anemia
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: